Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-42.09M
↓ 63% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-25.87M
Historical baseline
PeriodValueYoY Change
TTM$-42.09M-10.0%
2024$-38.26M-20.6%
2023$-31.71M-12.5%
2022$-28.18M+2.7%
2021$-28.95M+0.2%
2020$-29.00M-25.6%
2019$-23.09M-26.3%
2018$-18.29M-129.4%
2017$-7.97M+28.7%
2016$-11.19M-